CD4 and neoplasm: Foxp3+ Tregs is a highly immunosuppressive subset of CD4+ T cells that is critical in s uppressing proliferation and cytokine production of other T cells, inhibiting tumor-specific immune responses and maintaining peripheral immune tolerance in cancer patients [114].